Á. Ruibal
Impact in
-
- Breast Cancer Treatment Studies
- Protease and Inhibitor Mechanisms
-
- HER2/EGFR in Cancer Research
Papers in
- Oncology 24
- Cancer Risks and Factors 5
-
- Glycosylation and Glycoproteins Research 9
- Co-authors
- J Genollá (11 shared papers)Rámón Colomer (4 shared papers)Francisco J. Vizoso (9 shared papers)J. Collazos (8 shared papers)G Encabo (6 shared papers)Carlos López-Otı́n (3 shared papers)Irene Diez‐Itza (3 shared papers)Luis Sánchez‐Pulido (2 shared papers)
- Journals
- The International Journal of Biological Markers (13 papers)Acta Neurologica Scandinavica (2 papers)British Journal of Cancer (2 papers)Tumor Biology (2 papers)Scandinavian Journal of Clinical and Laboratory Investigation (2 papers)
- Partner nations
- SpainUnited StatesMexico
In The Last Decade
Á. Ruibal
72 papers receiving 527 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 97
- Oncology 148
- Reproductive Medicine 44
- Hepatology 26
- Radiology, Nuclear Medicine and Imaging 69
Countries citing papers authored by Á. Ruibal
This map shows the geographic impact of Á. Ruibal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Á. Ruibal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Á. Ruibal more than expected).
Fields of papers citing papers by Á. Ruibal
This network shows the impact of papers produced by Á. Ruibal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Á. Ruibal. The network helps show where Á. Ruibal may publish in the future.
Co-authors
The 25 scholars most cited alongside Á. Ruibal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Expression and prognostic significance of apolipoprotein D in breast cancer. | 1994 | 80 |
| 2 | 1989 | 50 | |
| 3 | 1999 | 28 | |
| 4 | 2006 | 27 | |
| 5 | 1986 | 27 | |
| 6 | 1992 | 25 | |
| 7 | 1996 | 17 | |
| 8 | 2002 | 17 | |
| 9 | Seric CA 19.9 levels in patients with non tumoral pathologies. Our experience in 892 cases. | 1986 | 17 |
| 10 | 1996 | 15 | |
| 11 | 1993 | 15 | |
| 12 | CA 15.3: early results of a new breast cancer marker. | 1986 | 15 |
| 13 | Serum CA 15.3 levels in patients with general pathology and malignant diseases (excluding breast cancer). | 1986 | 14 |
| 14 | Evaluation of human breast cysts according to their biochemical and hormonal composition, and cytologic examination. | 1990 | 12 |
| 15 | 2014 | 10 | |
| 16 | 2002 | 9 | |
| 17 | 2014 | 9 | |
| 18 | 1998 | 9 | |
| 19 | 1992 | 8 | |
| 20 | 1999 | 8 |
About Á. Ruibal
Á. Ruibal is a scholar working on Oncology, Molecular Biology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 76 papers that have together received 555 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (9 papers), Breast Cancer Treatment Studies (9 papers), Ovarian cancer diagnosis and treatment (7 papers), Medical Imaging Techniques and Applications (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Breast Lesions and Carcinomas (5 papers) and Cancer Risks and Factors (5 papers). The work is most often cited by research in Cancer Research (97 citations), Oncology (148 citations), Reproductive Medicine (44 citations), Hepatology (26 citations) and Radiology, Nuclear Medicine and Imaging (69 citations). Á. Ruibal has collaborated with scholars based in Spain, United States and Mexico. Frequent co-authors include J Genollá, Rámón Colomer, Francisco J. Vizoso, J. Collazos, G Encabo, Carlos López-Otı́n, Irene Diez‐Itza, Luis Sánchez‐Pulido, A.M. Merino and Jorge Tolivia. Their work appears in journals such as The International Journal of Biological Markers, Acta Neurologica Scandinavica, British Journal of Cancer, Tumor Biology and Scandinavian Journal of Clinical and Laboratory Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.